Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer
Industrial Technology
Healthcare
Software
Energy
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
INT
DA
DE
FR
SV
US
Main menu button
Team
Deals
Contact
Team
Deals
Contact
News
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
All
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
All
28 Feb 2024
Equity Research Enrad, Q4 2023: New orders may pick up later in 2024
Equity Research
Enrad
28 Feb 2024
Equity research Candles Scandinavia Q3 2023/2024: Better momentum could trigger rerating
Equity Research
Candles Scandinavia
28 Feb 2024
Carlsquare weekly market letter: Weight loss, defence and emerging markets in focus as market seeks next leg up
Equity Research
Carlsquare
27 Feb 2024
Equity research Zinzino, Q4 2023: Increased dividend proposed after a strong year
Equity Research
Zinzino
26 Feb 2024
Initiation of coverage GIAB: More profitable by focusing on electronics
Equity Research
26 Feb 2024
Equity research Candles Scandinavia, Q3 2023/2024: Signs of improvement
Equity Research
Candles Scandinavia
23 Feb 2024
Equity Research Enrad, Q4 2023: Twice as good results as expected
Equity Research
Enrad
23 Feb 2024
Equity Research ALM Equity, Q4 2023: Continues to develop its assets
Equity Research
ALM Equity
23 Feb 2024
Equity research Viva Wine Group, Q4 2023: Improved growth should strengthen margins
Equity Research
Viva Wine Group
22 Feb 2024
Equity reseach Viva Wine Group, Q4 2023: Strong growth, but profitability on the soft side
Equity Research
Viva Wine Group
22 Feb 2024
Equity Research ALM Equity, Q4 2023: Consolidates operations with a larger associate
Equity Research
ALM Equity
21 Feb 2024
Equity research Nosa Plugs Q4, 2023: Record-breaking sales funding the pipeline
Equity Research
Nosa Plugs
21 Feb 2024
Carlsquare weekly market letter: All eyes on Nvidia!
Equity Research
Carlsquare
19 Feb 2024
Equity Research Viva Wine Grooup: Preview, Q4 2023
Equity Research
Viva Wine Group
19 Feb 2024
Equity Research Ecoclime, Q4 2023: Lower costs set the stage for future profits
Equity Research
16 Feb 2024
First Impression Ecoclime, Q4 2023: Lower costs indicate rationalization
Equity Research
16 Feb 2024
Equity Research Nosa Plugs: First impression Q4, 2023
Equity Research
Nosa Plugs
15 Feb 2024
Equity research HANZA Q4 2023: Going on the offensive in a slower market
Equity Research
Hanza
14 Feb 2024
Carlsquare weekly market letter: Is a change of the wind in the making?
Equity Research
Carlsquare
13 Feb 2024
Equity research HANZA: First impression Q4, 2023
Equity Research
Hanza
1
…
15
16
17
18
19
…
64